Tissue sampling could originally only establish the diagnosis of lung cancer, but now sufficient tissue sampling is needed for next generation sequencing for epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), ‐etc‐. This evidence concerns the gene EGFR and lung carcinoma.